CD47 was highly expressed in bladder urothelial carcinoma (BLCA), BRCA, CESC, cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD) and ovarian cancer (Figure 1B). Here, CD47 is linked to bladder transitional cell carcinoma.